Clinical Trials Browser

Has results × Adenocarcinoma × Sorafenib × Clear all

NCT00661830 2013-11-21

Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)

Phase 2 Completed

103 enrolled 18 charts

Adenocarcinoma, Neoplasm Metastasis